Cargando…
Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort study
BACKGROUND: Glucocorticoids are widely used to reduce disease activity and inflammation in patients with a range of immune-mediated inflammatory diseases. It is uncertain whether or not low to moderate glucocorticoid dose increases cardiovascular risk. We aimed to quantify glucocorticoid dose-depend...
Autores principales: | Pujades-Rodriguez, Mar, Morgan, Ann W., Cubbon, Richard M., Wu, Jianhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714202/ https://www.ncbi.nlm.nih.gov/pubmed/33270649 http://dx.doi.org/10.1371/journal.pmed.1003432 |
Ejemplares similares
-
Glucocorticoid dose-dependent risk of type 2 diabetes in six immune-mediated inflammatory diseases: a population-based cohort analysis
por: Wu, Jianhua, et al.
Publicado: (2020) -
Oral glucocorticoids and incidence of hypertension in people with chronic inflammatory diseases: a population-based cohort study
por: Mebrahtu, Teumzghi F., et al.
Publicado: (2020) -
Dose Dependency of Iatrogenic Glucocorticoid Excess and Adrenal Insufficiency and Mortality: A Cohort Study in England
por: Mebrahtu, Teumzghi F, et al.
Publicado: (2019) -
Causes of Death in People With Cardiovascular Disease: A UK Biobank Cohort Study
por: Drozd, Michael, et al.
Publicado: (2021) -
Systemic Inflammation Is Associated With Future Risk of Fatal Infection: An Observational Cohort Study
por: Drozd, Michael, et al.
Publicado: (2022)